DW Profiles German Biotech CureVac’s Work To Develop Vaccines, Funding From Philanthropic Investors

Deutsche Welle: Cash injection spurs vaccination hopes
“The Bill & Melinda Gates Foundation has invested tens of millions in German biotech firm CureVac. The cash injection will help the company continue working on developing effective vaccines for diseases, including Ebola, HIV, and tuberculosis…” (Meyer, 8/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.